Central AsianResearch Index

MEDULLOBLASTOMA IN A 16-YEAR-OLD PATIENT: A CLINICAL CASE

Relevance: Brain tumors are children’s most common solid tumors, with medulloblastomas accounting for almost 20%. The Electronic Registry of Oncological Patients of the Republic of Kazakhstan (RK) reports 27 morphologically verified cases of medulloblastoma in 2021, 18 of them in children (66.6%). The aim was to show the feasibility of conducting a molecular genetic study to clarify the diagnosis of brain tumors using a clinical case as an example. Methods: The article describes a clinical case of a patient with medulloblastoma. The examinations included computed tomography of the brain, magnetic resonance imaging of the brain, and pathomorphological revision with an immunohistochemical examination of postoperative material. Results: The patient was admitted to the Center of Pediatric Oncology of “Kazakh Institute of Oncology and Radiology” JSC (Almaty, Kazakhstan) with a referral morphological diagnosis of “Ependymoma of the cerebellar vermis with compression of the 4th ventricle. Grade II. Condition – after ventricular operitoneostomy on the left side (14.11.2021), after microsurgical removal of the tumor (07.12.2021). 2nd clinical group.” Because of the atypical localization of the formation, a pathomorphological review with an immunohistochemical study of the postoperative material was carried out. Conclusion: the morphological picture and immunophenotype correspond to desmoplastic/nodular medulloblastoma, grade IV. ICD-O code 9471/3. The treatment tactics were revised based on morphological data. Conclusion: Medulloblastoma is a highly malignant tumor with an aggressive course. Choosing the right treatment tactics depends on a timely, accurate diagnosis, which makes the diagnosis a critical link in the patient management algorithm. In addition, it requires conducting a morphological and immunohistochemical examination. According to the 5th version of the 2021 WHO classification of CNS tumors, a molecular genetic study is required to accurately determine the morphological structure of the tumor and achieve a better response to therapy. In addition, it necessitates a revision of the relevant clinical guidelines adopted in the Republic of Kazakhstan

Сведения

Опубликовано
2022 · Т. 64, № 2, С. 39-43
Язык
Английский
ISSN
1684-937X · 2521-6414
Издатель
Kazakh Institute of Oncology and Radiology
Аффилиации
«Asfendiyarov Kazakh National Medical University» Non-profit JSC
«Kazakh Institute of Oncology and Radiology» JSC